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A signiﬁcant proportion of the human genome codes for transcription factors. Balanced activity of
transcriptional activators and repressors is essential for normal development and differentiation.
Previously we reported that a classical C2H2 zinc ﬁnger DNA binding protein ZNF652 functionally
interacts with CBFA2T3 to repress transcription of genes containing ZNF652 consensus DNA binding
sequence within the promoters of these target genes. Here we show that ZNF651 is a ZNF652 para-
logue that shares a common DNA binding sequence with ZNF652 and represses target gene expres-
sion through the formation of a CBFA2T3–ZNF651 corepressor complex. It is suggested that
CBFA2T3–ZNF651 and CBFA2T3–ZNF652 repressor complexes perform functionally similar roles in
a tissue-speciﬁc manner.
Structured summary:
MINT-7555667: CBFA2T3 (uniprotkb:O75081) physically interacts (MI:0915) with ZNF651 (uni-
protkb:Q9UFB7) by anti tag co-immunoprecipitation (MI:0007)
Crown Copyright  2010 Published by Elsevier B.V. on behalf of Federation of European Biochemical
society. All rights reserved.1. Introduction
Transcriptional activation and repression is critical in develop-
ment and differentiation. Although about 10% of proteins encoded
by the human genome are transcription factors, only a small num-
ber of these have been functionally characterised [1]. Transcription
factors directly bind their cognate DNA binding sequences gener-
ally located within the promoter regions of their target genes. A
number of these DNA binding transcription factors are evolution-
arily conserved, particularly within regions of the protein that di-
rectly bind the DNA sequences. For example, Gﬁ-1 and Gﬁ-1b are
highly conserved within their DNA binding zinc ﬁnger regions
and both recognise the same DNA binding motif. However, their
differing functions are attributed to dissimilarity between the
two proteins outside their zinc ﬁnger regions [2].
CBFA2T1, CBFA2T2 and CBFA2T3 (MTG8, R1 and 16, respec-
tively) constitute a group of ubiquitously expressed transcriptional
regulatory proteins sometimes referred to as the ‘‘ETO” family. ETOd by Elsevier B.V. on behalf of Fede
enetics Group, SA Pathology,
8222 3217.
. Kumar).proteins do not directly bind DNA, but exhibit their repressor
activity by interacting with transcription factors (for example,
BCL6, PLZF, Gﬁ-1, ZNF652) that bind directly to their cognate
DNA binding sequences located within the promoters of target
genes. ETOs are scaffold proteins that recruit a range of corepressor
proteins such as N-CoR, SMRT, Sin3A and ATN1 and HDACs to gen-
erate complexes that function to repress gene transcription [3].
We have previously shown that the classical C2H2 zinc ﬁnger
DNA binding protein ZNF652 speciﬁcally and functionally interacts
with the ETO protein CBFA2T3 to repress transcription [4]. The
CBFA2T3–ZNF652 complex was proposed to repress transcription
of genes that have roles in breast oncogenesis [4]. Subsequently,
we identiﬁed the ZNF652 consensus DNA binding sequence, and
showed that CBFA2T3–ZNF652 represses HEB expression by bind-
ing to a single ZNF652 DNA binding motif located within the HEB
promoter [5]. We have now identiﬁed ZNF651 (also called ZBTB47)
as a ZNF652 paralogue. The deduced ZNF652 and ZNF651 amino
acid sequences are highly conserved within the zinc ﬁnger region,
and we show that ZNF651 can also bind to the consensus ZNF652
DNA binding sequence. We present data showing that CBFA2T3–
ZNF651 functions as a repressor complex in a manner similar to
CBFA2T3–ZNF652. We also determined that both ZNF651 and
ZNF652 share a region of homology through which they interactration of European Biochemical society. All rights reserved.
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tionally similar roles in a tissue-speciﬁc manner.
2. Materials and methods
2.1. Plasmid constructs
Epitope-tagged CBFA2T3 and ZNF652 expression constructs
have been reported recently [5]. To generate HA- and Myc-
ZNF651 expression constructs, ZNF651 coding sequence was
ampliﬁed using forward 50-CACACACACACAGAATTCCCATGGGCTG-
CCTCCTGGATGGCTG and reverse 50-CACACACACACAGGATCCCT-
AGTTGTTGGCGTTCATCCTC primers from brain cDNA and cloned
in-frame with the respective tags at EcoRI and BglII sites in the
pCMV-HA and pCMV-Myc expression vectors (Clontech). To gener-
ate pGL2-IRF2BP1-TK-Luc construct for dual luciferase reporter
assays, a 435 bp region of the IRF2BP1 promoter was PCR ampliﬁed
using forward 50-CACACACAGGTACCTCCAGGTAGTGAGCGCTCAA-
GGTT and reverse 50-CACACACACAGGATCCCTCGAGAGAGCCTT-
GTCTCAGTTGTTTCTC primers from human genomic DNA and
cloned at KpnI–XhoI sites located upstream of a Herpes simplex
virus thymidine kinase (TK) gene promoter in the pGL2-TK-Luc
vector.
2.2. Cell lines and antibodies
HEK293T (human embryonic kidney) and HeLa (cervical carci-
noma) cells were purchased from the American Type Culture Col-
lection (Manassas, VA) and grown in the recommended media at
37 C in 5% CO2. Antibodies used were; afﬁnity-puriﬁed rabbit
anti-ZNF652 [4]; rat anti-HA (12CA5, Roche Diagnostics); mouse
anti-Myc (9E10: sc-40, Santa Cruz Biotechnology); rabbit anti-
rat-IgG-HRP (Dako Cytomation), sheep anti-mouse-IgG-HRP and
donkey anti-rabbit-IgG-HRP (Amersham Biosciences).
2.3. EMSA (electrophoretic mobility shift assay), co-
immunoprecipitations, promoter precipitation and Western blotting
Nuclear extracts from the HEK293T and HEK293T cells tran-
siently expressing either HA-ZNF651 or HA-ZNF652 were preparedFig. 1. ZNF651 and ZNF652 are paralogues. Alignment of the deduced amino acid sequen
domains are marked with lines above the sequence and amino acids conserved within tas previously reported [5]. Short double-stranded annealed DNA
carrying wild type and mutant sequences were used in normal
and supershift EMSA as reported [5]. Co-immunoprecipitations,
promoter precipitation and Western blots were performed as de-
scribed previously [5].
2.4. Dual luciferase reporter assays
Dual luciferase assays were performed using HeLa cells as pre-
viously reported [5]. Brieﬂy, HeLa cells were co-transfected with
the ﬁreﬂy luciferase expressing pGL2-IRF2BP1-TK-Luc and Renilla
luciferase expression plasmid pRL-TK and the indicated expression
constructs (see Fig. 4). The ﬁreﬂy luciferase activity was expressed
relative to the Renilla luciferase activity. All reporter assays were
performed in triplicate and repeated at least three times with the
data presented as mean ± S.E.
3. Results
3.1. ZNF651 and ZNF652 are paralogues that are differentially
expressed in human tissues
ZNF651 is located on chromosome 3 and encodes a 371 amino
acid protein that is shorter than the 606 amino acid ZNF652 pro-
tein encoded by the ZNF652 gene located on chromosome 17.
Alignment of the deduced amino acid sequences of ZNF651 and
ZNF652 shows 77% overall similarity. The two proteins are highly
conserved (95%) within their zinc ﬁnger regions. Besides this zinc
ﬁnger region, a short carboxy-terminal proline-rich sequence of
ZNF651 and ZNF652 is the only other region with signiﬁcant sim-
ilarity (85%) (Fig. 1). Whereas both ZNF651 and ZNF652 are differ-
entially expressed in different tissues, only ZNF652 is expressed in
blood and mammary tissue (Fig. 2).
3.2. ZNF651 and ZNF652 bind to the identical consensus DNA binding
sequence
Using a CASTing protocol, we previously identiﬁed NBNAVGG-
GTTAAN (where N = AGCT, B = GCT and V = AGC) as the ZNF652
DNA binding sequence [5]. As ZNF651 and ZNF652 shared 95% sim-ces of ZNF651 and ZNF652. Conserved regions are shown in yellow. The zinc ﬁnger
he carboxy-terminal proline-rich regions are underlined.
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Fig. 2. ZNF651 and ZNF652 are differentially expressed in different human tissues.
The graph shows levels of ZNF651 and ZNF652 expression in selected human tissues.
Data for the transcripts per million in the pool for each tissue was accessed
from http://www.ncbi.nlm.nih.gov/UniGene/ESTProﬁleViewer.cgi?uglist=Hs.409561
(ZNF651) and http://www.ncbi.nlm.nih.gov/UniGene/ESTProﬁleViewer.cgi?uglist=
Hs.463375 (ZNF652).
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ZNF651 binds to the ZNF652 consensus DNA binding sequence.
This was determined by an EMSA using nuclear extracts from
HEK293T cells ectopically expressing HA-tagged ZNF651 or
ZNF652 proteins. Ectopically expressed HA-ZNF651 and HA-
ZNF652 proteins were used due to unavailability of an EMSA com-
patible anti-ZNF651 antibody. Binding reactions were performed
by mixing the nuclear extracts and radio-labelled short double
stranded DNA probes carrying either wild type ZNF652 or mutant- - - - -
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Fig. 3. ZNF651 and ZNF652 proteins bind to the same DNA binding sequence. The
nuclear extracts from HEK293T cells ectopically expressing either HA-tagged
ZNF652 (lanes 4–9) or ZNF651 (lanes 10–15) were incubated with 32P-labelled wild
type (WT) probe consisting of consensus ZNF652 binding sequence, or a non-
speciﬁc (NS) probe containing a randomised sequence of the same length, and
analysed by EMSA. 18- and 35-mer oligonucleotide probes were used for ZNF651
and ZNF652 binding reactions, respectively. Binding reactions containing WT (lane
1, 18-mer), NS (lane 2, 18-mer) or WT (lane 3, 35-mer) oligonucleotide probes and
HEK293T nuclear extracts were used as controls. The anti-ZNF652 (lanes 6–7), anti-
HA (lanes 12–13) or appropriate non-speciﬁc (lanes 8–9 and 14–15) antibody was
added to the reactions for supershift analysis (lanes 6–9 and 12–15, respectively).
Protein–DNA complexes and protein–DNA-supershift (SS) complexes that super-
shifted only in the presence of anti-ZNF652 or anti-HA antibody are shown with
arrows.sequences and resolved on a non-denaturing acrylamide gel.
Whereas both the ZNF652 and ZNF651 proteins bound to the wild
type probes (Fig. 3, lanes 4 and 10) no such binding was seen with
the mutant probes (lanes 5 and 11). To conﬁrm the speciﬁcity of
protein–DNA complexes, rabbit anti-ZNF652 and rat anti-HA anti-
bodies were used in a supershift EMSA. Whereas the ZNF652– and
ZNF651–wild type DNA probe complexes supershifted in the pres-
ence of anti-ZNF652 (lane 6) and anti-HA (lane 12) antibodies,
respectively, no further mobility shift was detected in the presence
of appropriate non-speciﬁc antibodies (lanes 8 and 14). Taken to-
gether, these results suggest that both ZNF652 and ZNF651 can
speciﬁcally bind to the same DNA binding sequence that was pre-
viously identiﬁed as the consensus ZNF652 DNA binding sequence.
Although both proteins bind to the same DNA binding sequence,
subtle differences in their strength of binding may be present.
3.3. The CBFA2T3–ZNF651 complex mediates transcriptional
repression through a ZNF652 DNA binding sequence
IRF2BP1 was identiﬁed as one of several ZNF652 target genes
from our recent ChIP-chip assay (manuscript in preparation). The
pGL2-IRF2BP1-TK-Luc construct carrying an IRF2BP1 promoter re-
gion was used (Fig. 4) in a dual luciferase assay to determine if
CBFA2T3–ZNF651 complex is capable of mediating the transcrip-
tional repression through the consensus ZNF652 DNA binding se-
quence located within the IRF2BP1 promoter.
The pGL2-IRF2BP1-TK-Luc reporter showed a moderate level of
basal transcriptional activity. A dose-dependent decrease in lucif-
erase activity in response to increasing levels of exogenous
ZNF651 or ZNF652 was observed. This repression was further en-
hanced in the presence of increasing levels of CBFA2T3 (Fig. 4).
The results showed that both the CBFA2T3–ZNF651 and/orZNF651 (ng)
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Fig. 4. CBFA2T3 enhances ZNF651- and ZNF652-mediated transcriptional repres-
sion. Increasing levels of ZNF651 and ZNF652 result in a dose dependent decrease in
pGL2-IRF2BP1-TK-Luc reporter gene activity and this is further reduced in the
presence of CBFA2T3. Dual-luciferase reporter assays were performed to determine
the effect of ZNF651 and ZNF652 on transcriptional activity of the pGL2-IRF2BP1-
TK-Luc reporter construct (schematic shown below the graph). ZNF651/ZNF652
DNA binding site located at 928 to 941 within the IRF2BP1 promoter is shown.
The core ZNF652 DNA binding sequence is underlined. HeLa cells were transfected
with pGL2-IRF2BP1-TK-Luc together with or without different expression con-
structs as shown. pRL-TK-Renilla luciferase vector was used as a transfection
control. Promoter activity was calculated from the ratio of ﬁreﬂy to Renilla
luciferase activities. Repressive activity was enhanced in the presence of ZNF651 or
ZNF652 alone or in combination with CBFA2T3. Data shown is representative of
three independent experiments and is presented as mean ± S.E. (n = 3).
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Fig. 5. CBFA2T3 interacts to the ZNF651 bound to the ZNF652 DNA binding sequence and ZNF651 interacts with CBFA2T3 through its conserved proline-rich carboxy-
terminal sequence. (A) The 50-end biotinylated DNA carrying wild type (WT) or mutant (MT) DNA binding sequences were immobilised to streptavidin-coated magnetic
beads. Magnetic beads charged with DNA sequences (lanes 2 and 3) or uncharged beads (lane 4) were incubated with protein lysates from HEK293T cells ectopically
expressing Myc-tagged ZNF651 and CBFA2T3 proteins and then washed and eluted. Input and eluted proteins were analysed by Western blotting with anti-Myc antibody.
Low level of non-speciﬁc binding of the CBFA2T3 to the magnetic beads was detected. (B) HEK293T cells were transfected with constructs expressing HA-tagged ZNF651
proteins alone (lanes 1 and 4) or with Myc-CBFA2T3 (lanes 2 and 5) or Myc-CBFA2T3-3 (lanes 3 and 6) as shown. Cell lysates were co-immunoprecipitated with anti-Myc
antibody. Inputs (lanes 1–3) and immunoprecipitates (lanes 4–6) were Western blotted with anti-HA or anti-Myc antibodies.
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tion of the IRF2BP1 gene.
3.4. The CBFA2T3–ZNF651 complex speciﬁcally binds to the ZNF652
DNA binding sequence
An in vitro DNA binding assay was performed to determine
whether CBFA2T3 associates with ZNF651 when bound to the
ZNF652 DNA binding sequence. Nuclear extracts from HEK293T
cells ectopically expressing Myc-ZNF651 and Myc-CBFA2T3 pro-
teins were incubated with DNA fragments carrying either wild
type or mutant ZNF652 DNA binding sequences. Both ZNF651
and CBFA2T3 proteins bound to the wild type ZNF652 DNA binding
sequence but no such binding to the mutant sequences was ob-
served (Fig. 5). A low level of CBFA2T3 binding to the magnetic
beads charged with mutant DNA sequence appeared to be non-
speciﬁc as a comparable level of CBFA2T3 binding was also ob-
served in the uncharged beads (Fig. 5A; lanes 3 and 4).
3.5. ZNF651 interacts with CBFA2T3 via its carboxy-terminal proline-
rich region
We have previously shown that CBFA2T3 interacts with ZNF652
via its carboxy-terminal region and not through the DNA bindingzinc ﬁnger region [4]. We also showed that both NHR3 and NHR4
(CBFA2T3-3) motifs of CBFA2T3 are required for its interaction
with ZNF652 [5]. As the proline-rich region is the only conserved
domain between ZNF651 and ZNF652 outside the highly conserved
zinc ﬁnger region, we predicted that, like ZNF652, ZNF651 also
interacted with CBFA2T3 through this proline-rich region. Indeed,
both the full length CBFA2T3 and CBFA2T3-3 interacted with HA-
ZNF651 in co-immunoprecipitation assays performed on cells
ectopically expressing these proteins (Fig. 5B, lanes 5 and 6). How-
ever, ZNF651 did not interact with CBFA2T3-1 (containing NHR2),
CBFA2T3-2 (containing NHR3) or CBFA2T3-4 (containing NHR4)
(data not shown). The results suggested that CBFA2T3 also interacts
with ZNF651 through its carboxy-terminal proline-rich region.4. Discussion
Transcriptional regulation is an extremely complex and tightly
controlled process and is the result of ﬁnely balanced activities of
activator and repressor proteins. These controls are critical to a
multitude of developmental and differentiation processes while
deregulation of transcriptional regulation can lead to disease or
cancer. The observation that a signiﬁcant proportion of the human
genome encodes for transcription factors, whose key functional
PPVPHLPPPP
PPPPHLPPPP
ZNF652
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4751 565 606aa364742
4531 345 371aa87226
N-CoR 606-615 EPPPPLPPPP
N-CoR 1031-1040 RPPPPLIPSS
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SMRT 1664-1673 LYPPYLIRGY
N-terminal Zinc Fingers C-terminal
Fig. 6. Conserved proline-rich motifs facilitate functional protein–protein interactions. The diagram shows the structure of ZNF651 and ZNF652 proteins. An alignment of the
proline-rich regions of ZNF652, ZNF651, N-CoR, and SMRT proteins is also shown. Amino acids (aa) identical among the aligned sequences are shaded.
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signiﬁes the critical role they play in essential developmental
processes.
ETOs are modular proteins that do not directly bind DNA but
interact with transcription factors bound to their cognate DNA
binding sequences located within the promoter regions of target
genes and recruit a range of corepressors to facilitate transcrip-
tional repression. The ETO proteins interact with the zinc ﬁnger
proteins, Gﬁ-1, BCL6, PLZF, GATA-1 and transcription factors HEB
and TAL-1/SCL to repress gene expression [5]. We showed that
ETOs can also exhibit their transcriptional repressor activity by
interacting with a novel zinc ﬁnger protein ZNF652 [4]. In this re-
port we have now shown that CBFA2T3 can also exhibit its repres-
sive activity through a ZNF652 paralogue ZNF651 adding to the
existing range of ETOs-transcriptional complex-mediated gene
repression. We have presented in vitro and in vivo data showing
that ZNF651 and ZNF652 can bind to the same DNA binding con-
sensus sequence and that CBFA2T3 interacts with both of these
proteins. We have shown that both CBFA2T3–ZNF651 and
CBFA2T3–ZNF652 function as corepressors on the ZNF652 DNA
binding site located within the IRF2BP1 promoter. As CBFA2T3–
ZNF651 did not show transcriptional repression on the HEB pro-
moter ([5] and data not shown) and as ZNF651 and ZNF652 pro-
teins are differentially expressed among different tissues, we
premise that the two complexes may exhibit both tissue and gene
speciﬁc roles.
Although dysregulation of most ETO-based complexes is associ-
ated with leukaemia [3], down regulation of CBFA2T3 in breast tu-
mours and functional studies are consistent with a role of CBFA2T3
as a breast tumor suppressor [6]. We have reported that CBFA2T3
suppresses breast oncogenesis through its interaction with ZNF652
[4]. A recent report showed that CBFA2T3 interacts with the solu-
ble intracellular domain, termed s80, of ERBB4 and has a role in
ERBB4-dependent differentiation [7]. Whereas CBFA2T3 is ubiqui-
tously expressed, ZNF651 and ZNF652 show differential expression
among a range of human tissues. Therefore, we suggest that
CBFA2T3–ZNF651 and CBFA2T3–ZNF652 complexes exhibit their
transcriptional repressor function in a tissue-speciﬁc manner.
We showed that CBFA2T3 interacts with ZNF652 through a
proline-rich region located within the carboxy-terminal region
of ZNF652. We also showed that both NHR3 and NHR4 motifs
of CBFA2T3 are required for its interaction with ZNF652 [5]. Here
we have shown that CBFA2T3-3 carrying the NHR3–NHR4 motifs
interacts with ZNF651 and that this interaction most likely also
occurs through ZNF651 carboxy-terminal proline-rich region. This
is because, besides zinc ﬁnger regions, carboxy-terminal proline-
rich sequence is the only other region with signiﬁcant similarity
between ZNF651 and ZNF652. Previous studies on the ETO mem-
ber CBFA2T1 showed that both the NHR3 and NHR4 domains
were also required for its interaction with the corepressor N-
CoR [8,9] and this interaction occurs through a conserved pro-line-rich PPLXP motif within N-CoR [8]. A number of other pro-
teins have been reported to interact with MYND domains
(NHR4) through proline-rich domains and a PXLXP peptide motif
has been proposed (Fig. 6). ZNF651 and ZNF652 carboxy-terminal
proline-rich region conforms to this motif. MYND domains are de-
ﬁned by a C4–C2HC consensus and are frequently implicated in
transcriptional repression [10,11]. Interaction of ZNF651 and
ZNF652 with CBFA2T3 through their carboxy-terminal proline-
rich conserved sequence further emphasises the functional signif-
icance of proline-rich regions in protein–protein interaction and
cell signaling [12].
Similarly to other examples of paralogous transcription factors,
we ﬁnd that ZNF651 and ZNF652 share a number of similarities
with the Gﬁ-1 and Gﬁ-1b transcriptional repressor proteins. Both
ZNF651 and ZNF652 are highly conserved paralogous transcrip-
tional factors that are located on different chromosomes (3 and
17, respectively) and may have resulted from gene duplication.
Both proteins bind to the same DNA binding sequences located
within promoter regions of their target genes and interact with
the corepressor CBFA2T3 through a proline-rich region located
within their respective carboxyl-terminal regions. ZNF651 and
ZNF652 are conserved within their zinc ﬁnger and proline-rich re-
gions that are critical for DNA binding and CBFA2T3 corepressor
interaction, respectively. Likewise, Gﬁ-1 and Gﬁ-1b are highly con-
served pair of paralogous transcriptional repressors located on dif-
ferent chromosomes (chromosome 1 and 9, respectively) that may
also have resulted from gene duplication, and bind to the same
DNA binding sequence and interact with CBFA2T3. However, un-
like ZNF651 and ZNF652, Gﬁ proteins interact with CBFA2T3
through their evolutionarily conserved six carboxy-terminal zinc-
ﬁnger motifs.
Typically, ETO proteins form complexes with the DNA binding
proteins and recruit corepressors such as N-CoR, Sin3A, SMRT and
HDACs. It is not known whether CBFA2T3–ZNF652 recruits unique
co-factors although ZNF651- and ZNF652-speciﬁc protein motifs
may provide interfaces for interaction with as yet unidentiﬁed
co-factors thereby providing functional speciﬁcity to the two tran-
scriptional repressors. These ﬁndings further deﬁne the complex-
ity and diverse nature of the ETO-based repressor complexes.
ZNF651 and ZNF652 are differentially expressed in different tis-
sues (Fig. 2). Expression of ZNF651 is absent while ZNF652 is ex-
pressed in blood and mammary tissue. The presence of relatively
high ZNF652 expression in mammary tissue is consistent with the
original identiﬁcation of ZNF652 as a CBFA2T3 interacting protein
in a yeast two-hybrid screen of a breast cDNA library [4]. It is sug-
gested that although ZNF651 and ZNF652 transcription factors
interact with the same consensus DNA binding sequence, func-
tional speciﬁcity is provided by their tissue distribution. Future
work will determine tissue-speciﬁc functional differences be-
tween the CBFA2T3–ZNF651 and CBFA2T3–ZNF652 transcrip-
tional repressor complexes.
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